Northern Light partners with EBSCO Publishing to provide bio-pharma and health sciences news

NewsGuard 100/100 Score

Northern Light (www.northernlight.com) today announced a partnership with EBSCO Publishing (EBSCO) (www.ebscohost.com) that will let mutual customers directly search and access more than 4,000 bio-pharmaceutical, health sciences and general business magazines, journals and other news sources through Northern Light SinglePoint(TM) strategic research portals. SinglePoint users who also subscribe to EBSCO's Biomedical Reference Collection((TM)) and Business Source(®) Corporate may now opt to have that content integrated with their organization's strategic research portal.

SinglePoint is the only turnkey enterprise search application that provides centralized search, analysis, and access for diverse sources of internal, external, and licensed market intelligence. Offered in a secure, hosted, user self-service portal environment, SinglePoint is customized to the precise market research and competitive intelligence purposes of each of Northern Light's enterprise clients.

Biomedical Reference Collection provides managers and clinical researchers in industries such as bio-pharmaceutical, medical device manufacturing, biogenetics and public health with full-text access to more than 1,000 journals covering disciplines from biomedicine and health sciences to the health care system and pre-clinical sciences.

Business Source Corporate is designed to meet the diverse information needs of corporations. The database contains full text from nearly 3,000 quality magazines and journals, including general business periodicals, trade publications and top management journals. In addition, Business Source Corporate provides access to periodicals, country economic reports, company profiles, and industry reports. For mutual subscribers, Business Source Corporate pairs nicely with the thousands of business-oriented media sources and industry-authority blogs contained in Northern Light Business News.

EBSCO Publishing is the world's premier database aggregator serving the content needs of corporations, associations and organizations of all types. EBSCO offers a suite of nearly 300 full-text and secondary research databases providing content from tens of thousands of full-text journals, magazines, books, monographs, reports and various other publication types from renowned publishers. Databases provide information for areas ranging from research and development and corporate learning to departmental and industry-specific topics.

EBSCO Publishing President Tim Collins said, "EBSCO Publishing provides a wealth of information to organizations and researchers. Allowing access via SinglePoint will help mutual users make the rich resources they receive from EBSCOhost a part of their day using the latest information from journals and magazines to expand their business and market awareness."

"The addition to SinglePoint of this EBSCO content is a significant value-add to our clients," C. David Seuss, Northern Light's CEO, said. "For example, the pharmaceutical industry relies heavily on analysis of and discovery from comprehensive repositories of research documents for drug discovery and pharmaceutical market research - and nobody offers a richer library of such content than EBSCO."

Beyond providing a unified search index of all content contained in the portal, SinglePoint also offers the only automated "meaning extraction" application designed specifically for market intelligence, business analysis, product research, and market research. "Meaning extraction" imbues a search application with an in-depth understanding of the searched material. SinglePoint identifies meaning-loaded business concepts in a results list - business issues, strategic scenarios, companies, venture-funded companies, technologies, markets, job titles, government agencies, identified phrases, and research sources - to help researchers quickly identify and drill down into the most relevant documents for purposes of their specific inquiry.

SOURCE Northern Light

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses